Molecular Biology and Genomics — MCQs

Q: Transcription is the synthesis of:

A single-stranded complementary copy of DNA. **Explanation:** Transcription is the fundamental process of gene expression where the genetic information stored in **DNA** is copied into **RNA**. **Why Option A is Correct:** During transcription, the enzyme **RNA polymerase** reads the template strand of DNA (3' to 5') and synthesizes a **single-stranded** RNA molecule in the 5' to 3' direction. This RNA transcript is **complementary** to the DNA template strand (with Uracil replacing Thymine) and identical in sequence to the coding (non-template) strand. **Why Other Options are Incorrect:** * **Option B:** DNA is double-stranded, but the resulting RNA transcript is always single-stranded. Double-stranded DNA synthesis occurs during **Replication**, not transcription. * **Option C:** Synthesis of a complementary copy of RNA is characteristic of **RNA-dependent RNA replication** (seen in certain RNA viruses) or **Reverse Transcription** (where DNA is made from RNA). * **Option D:** While rRNA is indeed produced via transcription, it is only one specific type of RNA. Transcription encompasses the synthesis of **all** RNA types, including mRNA and tRNA; therefore, "a complementary copy of DNA" is the more accurate general definition. **High-Yield Clinical Pearls for NEET-PG:** * **Directionality:** Transcription always proceeds in the **5' → 3' direction**. * **Enzymes (Eukaryotes):** * **RNA Pol I:** Nucleolus; synthesizes 28S, 18S, and 5.8S **rRNA**. * **RNA Pol II:** Nucleoplasm; synthesizes **mRNA** and snRNA (Inhibited by **α-amanitin** from *Amanita phalloides* mushrooms). * **RNA Pol III:** Nucleoplasm; synthesizes **tRNA** and 5S rRNA. * **Prokaryotes:** A single RNA polymerase (multimeric enzyme) synthesizes all types of RNA. **Rifampicin** inhibits the β-subunit of this bacterial RNA polymerase.

Q: What hematological condition is associated with 'hn RNA'?

Beta-thalassemia. **Explanation:** The correct answer is **Beta-thalassemia**. **Underlying Concept:** Heterogeneous nuclear RNA (hnRNA) is the primary transcript produced by RNA polymerase II, containing both exons (coding) and introns (non-coding). Before it becomes functional mRNA, it must undergo **post-transcriptional processing**, which includes 5' capping, 3' polyadenylation, and **splicing** (removal of introns). In certain forms of **$\beta$-thalassemia**, mutations occur at the splice donor or acceptor sites. These mutations interfere with the normal splicing of hnRNA into mRNA. Consequently, the defective hnRNA cannot be processed correctly, leading to a deficiency of functional $\beta$-globin chains. This specific molecular pathology—**defective splicing of hnRNA**—is a classic high-yield association for $\beta$-thalassemia. **Analysis of Incorrect Options:** * **Sickle cell anemia:** This is caused by a **point mutation** (missense mutation) in the DNA where Glutamic acid is replaced by Valine at the 6th position of the $\beta$-globin chain. It does not involve hnRNA processing defects. * **Thalassemia (General):** While $\alpha$-thalassemia also involves globin chain deficiency, it is most commonly caused by **gene deletions** rather than the specific hnRNA splicing defects typically highlighted in $\beta$-thalassemia questions. **NEET-PG High-Yield Pearls:** * **hnRNA vs. mRNA:** hnRNA is the "pre-mRNA" found only in the nucleus; mRNA is the processed version found in the cytoplasm. * **Splicing Marker:** Small nuclear ribonucleoproteins (snRNPs or "snurps") are responsible for splicing hnRNA. * **$\beta$-Thalassemia Mutations:** Most $\beta$-thalassemias are due to point mutations (splicing, promoter, or chain termination), whereas $\alpha$-thalassemias are usually due to deletions.

Q: In a family, the mother is phenotypically normal, but the father has a genetic disease. All their daughters are carriers, and all their sons are normal. What is the pattern of inheritance of this disease?

X-linked recessive. ### Explanation The inheritance pattern described is characteristic of **X-linked recessive (XLR)** inheritance. **1. Why X-linked Recessive is Correct:** In XLR disorders, the father carries the mutated gene on his single X chromosome ($X^d Y$). Since he must pass his Y chromosome to his sons, **none of his sons will inherit the disease** or the gene from him. However, he must pass his X chromosome to all his daughters. Because the mother is phenotypically normal (assumed homozygous $XX$), the daughters receive one normal X from the mother and one mutated X from the father ($X^d X$), making them **obligate carriers**. **2. Why the Other Options are Incorrect:** * **X-linked Dominant:** If the father had an X-linked dominant condition, all daughters would inherit the mutated X and would be **clinically affected**, not just carriers. * **Autosomal Dominant:** A father with an autosomal dominant disease has a 50% chance of passing the trait to **both** sons and daughters. The gender-specific distribution (only daughters affected as carriers) rules this out. * **Autosomal Recessive:** For all daughters to be carriers and all sons to be normal, the mother would have to be homozygous normal and the father affected. While possible, autosomal inheritance does not typically show a 100% gender-segregated outcome in a standard pedigree analysis unless by chance; the "all daughters/all sons" pattern is the classic "textbook" description of X-linked transmission. **3. High-Yield NEET-PG Pearls:** * **Criss-cross inheritance:** XLR traits are transmitted from an affected father to his grandsons through his carrier daughters. * **Key Examples:** Hemophilia A and B, Duchenne Muscular Dystrophy (DMD), Red-Green Color Blindness, and G6PD Deficiency. * **Rule of Thumb:** If a father has an X-linked disease, his sons are safe (no male-to-male transmission), but all his daughters are carriers.

Q: What is the function of TTAGGG repeat-binding proteins?

Telomere maintenance. **Explanation:** The correct answer is **Telomere maintenance**. **1. Why Telomere Maintenance is Correct:** Telomeres are repetitive DNA sequences (TTAGGG in humans) located at the ends of linear chromosomes. **TTAGGG repeat-binding proteins**, primarily known as the **Shelterin complex** (including TRF1 and TRF2), bind specifically to these repeats. Their primary function is **telomere maintenance**, which involves protecting the chromosome ends from being recognized as double-stranded DNA breaks, preventing end-to-end fusion, and regulating the access of the enzyme telomerase to the DNA strand. **2. Why Other Options are Incorrect:** * **Telomere Elongation & Synthesis (Options A & C):** These processes are specifically carried out by **Telomerase**, a ribonucleoprotein (reverse transcriptase). While binding proteins regulate telomerase activity, they do not synthesize or elongate the DNA themselves. * **Telomere Capping (Option D):** While "capping" is a specific *mechanism* used by these proteins to protect the ends (forming the T-loop), "maintenance" is the broader, more accurate functional term used in standard biochemistry to describe the overall stability and regulation of telomeric length and integrity. **3. Clinical Pearls for NEET-PG:** * **The End Replication Problem:** DNA polymerase cannot replicate the 3' end of linear chromosomes, leading to progressive shortening. * **Hayflick Limit:** The finite number of times a normal somatic cell population will divide before cell division stops (senescence), governed by telomere length. * **Cancer Link:** Approximately 85–90% of cancer cells upregulate **telomerase**, allowing them to bypass senescence and achieve "immortality." * **Shelterin Complex:** Key proteins include TRF1, TRF2, RAP1, TIN2, TPP1, and POT1. Mutations in these can lead to **Dyskeratosis Congenita**.

Q: A potent inhibitor of protein synthesis that acts as an analogue of aminoacyl t-RNA is:

Puromycin. **Explanation:** **Puromycin** is the correct answer because it is a structural analogue of the 3' end of **aminoacyl-tRNA** (specifically tyrosinyl-tRNA). Due to this structural similarity, it enters the 'A' site of the ribosome during translation in both prokaryotes and eukaryotes. It incorporates itself into the growing polypeptide chain, leading to **premature chain termination** and the release of incomplete peptides. **Analysis of Incorrect Options:** * **Mitomycin C:** This is an alkylating agent that causes **DNA cross-linking**, primarily inhibiting DNA synthesis rather than acting as a tRNA analogue. * **Streptomycin:** An aminoglycoside that binds to the **30S ribosomal subunit**. It interferes with the initiation of protein synthesis and causes misreading of mRNA, but it does not mimic tRNA. * **Nalidixic Acid:** A quinolone that inhibits **DNA Gyrase** (Topoisomerase II) in bacteria, thereby preventing DNA replication. **High-Yield Clinical Pearls for NEET-PG:** * **Puromycin Unique Feature:** It is non-selective and inhibits protein synthesis in **both prokaryotes and eukaryotes**, making it unsuitable for clinical use as an antibiotic but useful in research. * **Inhibitors of the 50S Subunit:** Remember the mnemonic **"CLEAN"** (Chloramphenicol, Clindamycin, Erythromycin/Macrolides, Azithromycin, Linezolid). * **Inhibitors of the 30S Subunit:** Remember **"AT"** (Aminoglycosides, Tetracyclines). * **Diphtheria Toxin:** Inhibits eukaryotic translation by ADP-ribosylation of **Elongation Factor-2 (EF-2)**.

Q: Xeroderma pigmentosum is caused due to a defect in which of the following processes?

Nucleotide excision repair. **Explanation:** **Xeroderma Pigmentosum (XP)** is an autosomal recessive genetic disorder characterized by extreme sensitivity to ultraviolet (UV) radiation. **Why Nucleotide Excision Repair (NER) is correct:** UV light causes the formation of **pyrimidine dimers** (specifically thymine dimers) in DNA, which distort the double helix. In healthy individuals, these bulky lesions are removed via the **Nucleotide Excision Repair (NER)** pathway. This process involves specific endonucleases (XP proteins A through G) that "cut" the damaged strand, followed by DNA polymerase and ligase to fill the gap. In XP patients, a deficiency in these **UV-specific endonucleases** prevents the repair of these dimers, leading to accumulated mutations and carcinogenesis. **Why other options are incorrect:** * **Base pairing:** Refers to the hydrogen bonding between A-T and G-C; while dimers disrupt this, the *defect* is in the repair mechanism, not the chemical property of base pairing itself. * **Mismatch repair (MMR):** This system corrects errors (like mispaired bases) that occur during DNA replication. Defects in MMR lead to **Lynch Syndrome** (Hereditary Non-Polyposis Colorectal Cancer). * **Translocation:** This is a chromosomal abnormality where a segment of one chromosome breaks off and attaches to another (e.g., t(9;22) in CML). It is not a DNA repair pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Severe sunburn on minimal sun exposure, "parchment-like" skin, excessive freckling, and telangiectasia. * **Complications:** 2000-fold increased risk of skin cancers (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma) before age 10. * **Key Enzyme:** The most common defect is in **UV-specific endonuclease**. * **Contrast:** While XP involves NER, **Ataxia-telangiectasia** involves defects in repairing double-strand breaks.

Q: RNA polymerase does not require:

Primer. **Explanation:** The fundamental difference between DNA replication and transcription lies in the requirement for a primer. **RNA Polymerase** is capable of initiating the synthesis of an RNA chain *de novo* by joining two nucleotides together. In contrast, DNA Polymerase requires a pre-existing 3'-OH group (provided by an RNA primer) to begin polymerization. * **Why Option D is Correct:** RNA polymerase can initiate transcription by simply binding to a specific promoter sequence on the DNA. It does not require a primer to start the synthesis of the RNA strand. * **Why Option A is Incorrect:** RNA polymerase requires a **double-stranded DNA (dsDNA)** template. It reads the template strand in the 3' → 5' direction to synthesize RNA in the 5' → 3' direction. * **Why Option B is Incorrect:** Transcription requires **activated precursors** in the form of ribonucleoside triphosphates (ATP, GTP, UTP, and CTP). The energy for phosphodiester bond formation is derived from the cleavage of high-energy phosphate bonds in these nucleotides. * **Why Option C is Incorrect:** RNA polymerase is a metalloenzyme. It requires **divalent metal ions** (usually $Mg^{2+}$ or $Mn^{2+}$) as cofactors to stabilize the transition state and facilitate the catalytic process. **High-Yield Facts for NEET-PG:** * **Rifampicin:** Inhibits the $\beta$-subunit of bacterial RNA polymerase, preventing the initiation of transcription (used in Tuberculosis). * **$\alpha$-Amanitin:** A toxin from the *Amanita phalloides* mushroom that specifically inhibits RNA Polymerase II, leading to liver failure. * **Sigma ($\sigma$) Factor:** A subunit of prokaryotic RNA polymerase required for the **recognition of the promoter** site; it dissociates after the initiation of transcription.

Q: Which is the longest chromosome?

Chromosome 1. **Explanation:** In the human genome, chromosomes are numbered roughly in descending order of their physical size (length of DNA and number of base pairs), with the exception of the sex chromosomes. **1. Why Chromosome 1 is correct:** Chromosome 1 is the **largest (longest) human autosome**. It contains approximately **249 million base pairs**, representing about 8% of the total DNA in a human cell. It also boasts the highest gene density, housing over 2,000 identified genes. In a standard karyotype, it is the first chromosome displayed due to its superior length. **2. Why the other options are incorrect:** * **Chromosome 21:** This is the **smallest human autosome** (by base pair count, though Chromosome 22 was historically thought to be smaller). It contains roughly 48 million base pairs. Clinical significance: Trisomy 21 causes Down Syndrome. * **Chromosome 14:** This is a medium-sized acrocentric chromosome. It is significant in immunology as it contains the Gene locus for the Immunoglobulin Heavy chain (IgH). * **Chromosome X:** While large, the X chromosome ranks 8th in terms of size (approx. 155 million base pairs), making it significantly shorter than Chromosome 1. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Longest Chromosome:** Chromosome 1. * **Smallest Chromosome:** Chromosome Y (in terms of total base pairs), followed by Chromosome 21 (smallest autosome). * **Gene Richest Chromosome:** Chromosome 1. * **Gene Poorest Chromosome:** Chromosome Y. * **Acrocentric Chromosomes:** 13, 14, 15, 21, and 22 (Important for Robertsonian translocations). * **Denver Classification:** Chromosomes are classified into 7 groups (A-G) based on size and centromere position; Chromosome 1 belongs to **Group A** (large metacentric).

A pregnant woman with a family history of fragile X syndrome undergoes prenatal testing of her fetus. PCR analysis to amplify the appropriate region of the FMR1 gene is attempted using DNA from amniotic fluid cells, but no amplified products are obtained. Which of the following is the most appropriate next step?

Q10Easy

Which is the longest chromosome?

Molecular Biology and Genomics Indian Medical PG Practice Questions and MCQs

Question 1: Transcription is the synthesis of:

A. A single-stranded complementary copy of DNA (Correct Answer)
B. A double-stranded complementary copy of DNA
C. A complementary copy of RNA
D. A complementary copy of rRNA

Explanation: **Explanation:** Transcription is the fundamental process of gene expression where the genetic information stored in **DNA** is copied into **RNA**. **Why Option A is Correct:** During transcription, the enzyme **RNA polymerase** reads the template strand of DNA (3' to 5') and synthesizes a **single-stranded** RNA molecule in the 5' to 3' direction. This RNA transcript is **complementary** to the DNA template strand (with Uracil replacing Thymine) and identical in sequence to the coding (non-template) strand. **Why Other Options are Incorrect:** * **Option B:** DNA is double-stranded, but the resulting RNA transcript is always single-stranded. Double-stranded DNA synthesis occurs during **Replication**, not transcription. * **Option C:** Synthesis of a complementary copy of RNA is characteristic of **RNA-dependent RNA replication** (seen in certain RNA viruses) or **Reverse Transcription** (where DNA is made from RNA). * **Option D:** While rRNA is indeed produced via transcription, it is only one specific type of RNA. Transcription encompasses the synthesis of **all** RNA types, including mRNA and tRNA; therefore, "a complementary copy of DNA" is the more accurate general definition. **High-Yield Clinical Pearls for NEET-PG:** * **Directionality:** Transcription always proceeds in the **5' → 3' direction**. * **Enzymes (Eukaryotes):** * **RNA Pol I:** Nucleolus; synthesizes 28S, 18S, and 5.8S **rRNA**. * **RNA Pol II:** Nucleoplasm; synthesizes **mRNA** and snRNA (Inhibited by **α-amanitin** from *Amanita phalloides* mushrooms). * **RNA Pol III:** Nucleoplasm; synthesizes **tRNA** and 5S rRNA. * **Prokaryotes:** A single RNA polymerase (multimeric enzyme) synthesizes all types of RNA. **Rifampicin** inhibits the β-subunit of this bacterial RNA polymerase.

Question 2: What hematological condition is associated with 'hn RNA'?

A. Thalassemia
B. Sickle cell anemia
C. Beta-thalassemia (Correct Answer)
D. None of the above

Explanation: **Explanation:** The correct answer is **Beta-thalassemia**. **Underlying Concept:** Heterogeneous nuclear RNA (hnRNA) is the primary transcript produced by RNA polymerase II, containing both exons (coding) and introns (non-coding). Before it becomes functional mRNA, it must undergo **post-transcriptional processing**, which includes 5' capping, 3' polyadenylation, and **splicing** (removal of introns). In certain forms of **$\beta$-thalassemia**, mutations occur at the splice donor or acceptor sites. These mutations interfere with the normal splicing of hnRNA into mRNA. Consequently, the defective hnRNA cannot be processed correctly, leading to a deficiency of functional $\beta$-globin chains. This specific molecular pathology—**defective splicing of hnRNA**—is a classic high-yield association for $\beta$-thalassemia. **Analysis of Incorrect Options:** * **Sickle cell anemia:** This is caused by a **point mutation** (missense mutation) in the DNA where Glutamic acid is replaced by Valine at the 6th position of the $\beta$-globin chain. It does not involve hnRNA processing defects. * **Thalassemia (General):** While $\alpha$-thalassemia also involves globin chain deficiency, it is most commonly caused by **gene deletions** rather than the specific hnRNA splicing defects typically highlighted in $\beta$-thalassemia questions. **NEET-PG High-Yield Pearls:** * **hnRNA vs. mRNA:** hnRNA is the "pre-mRNA" found only in the nucleus; mRNA is the processed version found in the cytoplasm. * **Splicing Marker:** Small nuclear ribonucleoproteins (snRNPs or "snurps") are responsible for splicing hnRNA. * **$\beta$-Thalassemia Mutations:** Most $\beta$-thalassemias are due to point mutations (splicing, promoter, or chain termination), whereas $\alpha$-thalassemias are usually due to deletions.

Question 3: In a family, the mother is phenotypically normal, but the father has a genetic disease. All their daughters are carriers, and all their sons are normal. What is the pattern of inheritance of this disease?

A. X-linked recessive (Correct Answer)
B. X-linked dominant
C. Autosomal dominant
D. Autosomal recessive

Explanation: ### Explanation The inheritance pattern described is characteristic of **X-linked recessive (XLR)** inheritance. **1. Why X-linked Recessive is Correct:** In XLR disorders, the father carries the mutated gene on his single X chromosome ($X^d Y$). Since he must pass his Y chromosome to his sons, **none of his sons will inherit the disease** or the gene from him. However, he must pass his X chromosome to all his daughters. Because the mother is phenotypically normal (assumed homozygous $XX$), the daughters receive one normal X from the mother and one mutated X from the father ($X^d X$), making them **obligate carriers**. **2. Why the Other Options are Incorrect:** * **X-linked Dominant:** If the father had an X-linked dominant condition, all daughters would inherit the mutated X and would be **clinically affected**, not just carriers. * **Autosomal Dominant:** A father with an autosomal dominant disease has a 50% chance of passing the trait to **both** sons and daughters. The gender-specific distribution (only daughters affected as carriers) rules this out. * **Autosomal Recessive:** For all daughters to be carriers and all sons to be normal, the mother would have to be homozygous normal and the father affected. While possible, autosomal inheritance does not typically show a 100% gender-segregated outcome in a standard pedigree analysis unless by chance; the "all daughters/all sons" pattern is the classic "textbook" description of X-linked transmission. **3. High-Yield NEET-PG Pearls:** * **Criss-cross inheritance:** XLR traits are transmitted from an affected father to his grandsons through his carrier daughters. * **Key Examples:** Hemophilia A and B, Duchenne Muscular Dystrophy (DMD), Red-Green Color Blindness, and G6PD Deficiency. * **Rule of Thumb:** If a father has an X-linked disease, his sons are safe (no male-to-male transmission), but all his daughters are carriers.

Question 4: What is the function of TTAGGG repeat-binding proteins?

A. Telomere elongation
B. Telomere maintenance (Correct Answer)
C. Telomere synthesis
D. Telomere capping

Explanation: **Explanation:** The correct answer is **Telomere maintenance**. **1. Why Telomere Maintenance is Correct:** Telomeres are repetitive DNA sequences (TTAGGG in humans) located at the ends of linear chromosomes. **TTAGGG repeat-binding proteins**, primarily known as the **Shelterin complex** (including TRF1 and TRF2), bind specifically to these repeats. Their primary function is **telomere maintenance**, which involves protecting the chromosome ends from being recognized as double-stranded DNA breaks, preventing end-to-end fusion, and regulating the access of the enzyme telomerase to the DNA strand. **2. Why Other Options are Incorrect:** * **Telomere Elongation & Synthesis (Options A & C):** These processes are specifically carried out by **Telomerase**, a ribonucleoprotein (reverse transcriptase). While binding proteins regulate telomerase activity, they do not synthesize or elongate the DNA themselves. * **Telomere Capping (Option D):** While "capping" is a specific *mechanism* used by these proteins to protect the ends (forming the T-loop), "maintenance" is the broader, more accurate functional term used in standard biochemistry to describe the overall stability and regulation of telomeric length and integrity. **3. Clinical Pearls for NEET-PG:** * **The End Replication Problem:** DNA polymerase cannot replicate the 3' end of linear chromosomes, leading to progressive shortening. * **Hayflick Limit:** The finite number of times a normal somatic cell population will divide before cell division stops (senescence), governed by telomere length. * **Cancer Link:** Approximately 85–90% of cancer cells upregulate **telomerase**, allowing them to bypass senescence and achieve "immortality." * **Shelterin Complex:** Key proteins include TRF1, TRF2, RAP1, TIN2, TPP1, and POT1. Mutations in these can lead to **Dyskeratosis Congenita**.

Question 5: A potent inhibitor of protein synthesis that acts as an analogue of aminoacyl t-RNA is:

A. Mitomycin C
B. Streptomycin
C. Nalidixic acid
D. Puromycin (Correct Answer)

Explanation: **Explanation:** **Puromycin** is the correct answer because it is a structural analogue of the 3' end of **aminoacyl-tRNA** (specifically tyrosinyl-tRNA). Due to this structural similarity, it enters the 'A' site of the ribosome during translation in both prokaryotes and eukaryotes. It incorporates itself into the growing polypeptide chain, leading to **premature chain termination** and the release of incomplete peptides. **Analysis of Incorrect Options:** * **Mitomycin C:** This is an alkylating agent that causes **DNA cross-linking**, primarily inhibiting DNA synthesis rather than acting as a tRNA analogue. * **Streptomycin:** An aminoglycoside that binds to the **30S ribosomal subunit**. It interferes with the initiation of protein synthesis and causes misreading of mRNA, but it does not mimic tRNA. * **Nalidixic Acid:** A quinolone that inhibits **DNA Gyrase** (Topoisomerase II) in bacteria, thereby preventing DNA replication. **High-Yield Clinical Pearls for NEET-PG:** * **Puromycin Unique Feature:** It is non-selective and inhibits protein synthesis in **both prokaryotes and eukaryotes**, making it unsuitable for clinical use as an antibiotic but useful in research. * **Inhibitors of the 50S Subunit:** Remember the mnemonic **"CLEAN"** (Chloramphenicol, Clindamycin, Erythromycin/Macrolides, Azithromycin, Linezolid). * **Inhibitors of the 30S Subunit:** Remember **"AT"** (Aminoglycosides, Tetracyclines). * **Diphtheria Toxin:** Inhibits eukaryotic translation by ADP-ribosylation of **Elongation Factor-2 (EF-2)**.

Question 6: Which type of RNA molecule undergoes the least post-translational modification?

A. Transfer RNA (t-RNA)
B. Prokaryotic ribosomal RNA (r-RNA)
C. Eukaryotic ribosomal RNA (r-RNA)
D. Prokaryotic messenger RNA (mRNA) (Correct Answer)

Explanation: **Explanation** In molecular biology, the extent of post-transcriptional modification (often referred to in this context as RNA processing) varies significantly between species and RNA types. **Why Prokaryotic mRNA is the Correct Answer:** In prokaryotes, transcription and translation are **coupled**, meaning translation begins even before the mRNA synthesis is complete. Because there is no nuclear membrane to separate these processes, prokaryotic mRNA is used immediately by ribosomes. Consequently, it undergoes **minimal to no modification**—it lacks a 5' cap, a poly-A tail, and introns (splicing is absent). This allows for rapid gene expression but results in a very short half-life for the molecule. **Analysis of Incorrect Options:** * **t-RNA (Option A):** These are the most extensively modified RNA molecules. They undergo 5' and 3' trimming, base modifications (e.g., pseudouridine, dihydrouridine), and the addition of the CCA tail at the 3' end. * **Eukaryotic r-RNA (Option C):** These undergo significant processing, including cleavage of a large 45S precursor and extensive methylation/nucleoside modification guided by snoRNAs. * **Prokaryotic r-RNA (Option B):** While less complex than eukaryotic r-RNA, prokaryotic r-RNAs are still synthesized as a large polycistronic precursor that must be cleaved and methylated to form functional 16S, 23S, and 5S subunits. **NEET-PG High-Yield Pearls:** * **Eukaryotic mRNA:** Unlike prokaryotic mRNA, it undergoes three major modifications: **5' Capping** (7-methylguanosine), **3' Polyadenylation** (Poly-A tail), and **Splicing** (removal of introns). * **Polycistronic vs. Monocistronic:** Prokaryotic mRNA is typically polycistronic (codes for multiple proteins), whereas eukaryotic mRNA is monocistronic. * **Clinical Link:** Many antibiotics (like Macrolides and Tetracyclines) exploit the structural differences between prokaryotic and eukaryotic ribosomal RNA to achieve selective toxicity.

Question 7: Xeroderma pigmentosum is caused due to a defect in which of the following processes?

A. Base pairing
B. Nucleotide excision repair (Correct Answer)
C. Mismatch repair
D. Translocation

Explanation: **Explanation:** **Xeroderma Pigmentosum (XP)** is an autosomal recessive genetic disorder characterized by extreme sensitivity to ultraviolet (UV) radiation. **Why Nucleotide Excision Repair (NER) is correct:** UV light causes the formation of **pyrimidine dimers** (specifically thymine dimers) in DNA, which distort the double helix. In healthy individuals, these bulky lesions are removed via the **Nucleotide Excision Repair (NER)** pathway. This process involves specific endonucleases (XP proteins A through G) that "cut" the damaged strand, followed by DNA polymerase and ligase to fill the gap. In XP patients, a deficiency in these **UV-specific endonucleases** prevents the repair of these dimers, leading to accumulated mutations and carcinogenesis. **Why other options are incorrect:** * **Base pairing:** Refers to the hydrogen bonding between A-T and G-C; while dimers disrupt this, the *defect* is in the repair mechanism, not the chemical property of base pairing itself. * **Mismatch repair (MMR):** This system corrects errors (like mispaired bases) that occur during DNA replication. Defects in MMR lead to **Lynch Syndrome** (Hereditary Non-Polyposis Colorectal Cancer). * **Translocation:** This is a chromosomal abnormality where a segment of one chromosome breaks off and attaches to another (e.g., t(9;22) in CML). It is not a DNA repair pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Severe sunburn on minimal sun exposure, "parchment-like" skin, excessive freckling, and telangiectasia. * **Complications:** 2000-fold increased risk of skin cancers (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma) before age 10. * **Key Enzyme:** The most common defect is in **UV-specific endonuclease**. * **Contrast:** While XP involves NER, **Ataxia-telangiectasia** involves defects in repairing double-strand breaks.

Question 8: RNA polymerase does not require:

A. Template (ds DNA)
B. Activated precursors (ATP, GTP, UTP, CTP)
C. Divalent metal ions (Mn2+, Mg2+)
D. Primer (Correct Answer)

Explanation: **Explanation:** The fundamental difference between DNA replication and transcription lies in the requirement for a primer. **RNA Polymerase** is capable of initiating the synthesis of an RNA chain *de novo* by joining two nucleotides together. In contrast, DNA Polymerase requires a pre-existing 3'-OH group (provided by an RNA primer) to begin polymerization. * **Why Option D is Correct:** RNA polymerase can initiate transcription by simply binding to a specific promoter sequence on the DNA. It does not require a primer to start the synthesis of the RNA strand. * **Why Option A is Incorrect:** RNA polymerase requires a **double-stranded DNA (dsDNA)** template. It reads the template strand in the 3' → 5' direction to synthesize RNA in the 5' → 3' direction. * **Why Option B is Incorrect:** Transcription requires **activated precursors** in the form of ribonucleoside triphosphates (ATP, GTP, UTP, and CTP). The energy for phosphodiester bond formation is derived from the cleavage of high-energy phosphate bonds in these nucleotides. * **Why Option C is Incorrect:** RNA polymerase is a metalloenzyme. It requires **divalent metal ions** (usually $Mg^{2+}$ or $Mn^{2+}$) as cofactors to stabilize the transition state and facilitate the catalytic process. **High-Yield Facts for NEET-PG:** * **Rifampicin:** Inhibits the $\beta$-subunit of bacterial RNA polymerase, preventing the initiation of transcription (used in Tuberculosis). * **$\alpha$-Amanitin:** A toxin from the *Amanita phalloides* mushroom that specifically inhibits RNA Polymerase II, leading to liver failure. * **Sigma ($\sigma$) Factor:** A subunit of prokaryotic RNA polymerase required for the **recognition of the promoter** site; it dissociates after the initiation of transcription.

Question 9: A pregnant woman with a family history of fragile X syndrome undergoes prenatal testing of her fetus. PCR analysis to amplify the appropriate region of the FMR1 gene is attempted using DNA from amniotic fluid cells, but no amplified products are obtained. Which of the following is the most appropriate next step?

A. Routine karyotyping of the amniotic fluid cells
B. Routine karyotyping of the unaffected father
C. Southern blot analysis of DNA from the amniotic fluid cells (Correct Answer)
D. PCR analysis of the mother's FMR1 gene

Explanation: **Explanation:** **1. Why Southern Blot is the Correct Choice:** Fragile X syndrome is caused by a **CGG trinucleotide repeat expansion** in the 5' untranslated region of the *FMR1* gene. In a "full mutation" (>200 repeats), the large size of the expansion and the high GC content make it extremely difficult to amplify using standard **PCR**. Furthermore, full mutations are associated with extensive **DNA methylation**, which further inhibits PCR amplification. When PCR fails to produce a band in a suspected case, it often indicates the presence of a large expansion that the technique cannot bridge. **Southern blot analysis** is the gold standard for detecting large expansions and assessing the methylation status of the *FMR1* gene, making it the necessary next step for definitive prenatal diagnosis. **2. Why Other Options are Incorrect:** * **A & B (Karyotyping):** While Fragile X was historically diagnosed via cytogenetics (showing a "fragile" site on the X chromosome in folate-deficient medium), this method is unreliable and has been replaced by molecular techniques. Routine karyotyping lacks the resolution to detect trinucleotide repeats. * **D (PCR of the mother):** While the mother is likely a carrier (pre-mutation), testing her does not provide the diagnosis for the fetus. The goal of prenatal testing is to determine the expansion status of the fetal DNA specifically. **3. Clinical Pearls for NEET-PG:** * **Genetics:** Fragile X is the most common cause of **inherited** intellectual disability and the second most common genetic cause (after Down Syndrome). * **Anticipation:** It exhibits "genetic anticipation," where the repeat length increases and symptoms worsen in successive generations. * **Clinical Triad:** Post-pubertal macroorchidism, long face with a prominent jaw, and large everted ears. * **Molecular Mechanism:** Full mutation (>200 repeats) leads to **hypermethylation** of the *FMR1* promoter, resulting in gene silencing (loss of FMRP protein).

Question 10: Which is the longest chromosome?

A. Chromosome 1 (Correct Answer)
B. Chromosome 21
C. Chromosome 14
D. Chromosome X

Explanation: **Explanation:** In the human genome, chromosomes are numbered roughly in descending order of their physical size (length of DNA and number of base pairs), with the exception of the sex chromosomes. **1. Why Chromosome 1 is correct:** Chromosome 1 is the **largest (longest) human autosome**. It contains approximately **249 million base pairs**, representing about 8% of the total DNA in a human cell. It also boasts the highest gene density, housing over 2,000 identified genes. In a standard karyotype, it is the first chromosome displayed due to its superior length. **2. Why the other options are incorrect:** * **Chromosome 21:** This is the **smallest human autosome** (by base pair count, though Chromosome 22 was historically thought to be smaller). It contains roughly 48 million base pairs. Clinical significance: Trisomy 21 causes Down Syndrome. * **Chromosome 14:** This is a medium-sized acrocentric chromosome. It is significant in immunology as it contains the Gene locus for the Immunoglobulin Heavy chain (IgH). * **Chromosome X:** While large, the X chromosome ranks 8th in terms of size (approx. 155 million base pairs), making it significantly shorter than Chromosome 1. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Longest Chromosome:** Chromosome 1. * **Smallest Chromosome:** Chromosome Y (in terms of total base pairs), followed by Chromosome 21 (smallest autosome). * **Gene Richest Chromosome:** Chromosome 1. * **Gene Poorest Chromosome:** Chromosome Y. * **Acrocentric Chromosomes:** 13, 14, 15, 21, and 22 (Important for Robertsonian translocations). * **Denver Classification:** Chromosomes are classified into 7 groups (A-G) based on size and centromere position; Chromosome 1 belongs to **Group A** (large metacentric).

Practice by Chapter

DNA Replication and Repair Mechanisms

Practice Questions

Transcription Factors and Gene Regulation

Practice Questions

Epigenetics and DNA Methylation

Practice Questions

RNA Processing and Splicing

Practice Questions

miRNA and RNA Interference

Practice Questions

Protein Synthesis and Post-Translational Modifications

Practice Questions

Genomics and Human Genome Project

Practice Questions

Single Nucleotide Polymorphisms

Practice Questions

Gene Therapy Approaches

Practice Questions

CRISPR-Cas9 and Genome Editing

Practice Questions

DNA Fingerprinting and Forensics

Practice Questions

Molecular Basis of Genetic Diseases

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free